Series B funding round for Checkmate Pharmaceuticals raising $27M in June 2017
Series B funding round for Checkmate Pharmaceuticals raising $27M in June 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Accelerator | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Jason Wang |
| Angel | Jon Brelig |
| Angel | Carol Gallagher |
| Angel | James Park |
| Angel | Ralph Gootee |
| Angel | Manik Gupta |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$154M
Top Valuation
-
Checkmate Pharmaceuticals raised $27M in a Series B round.
The round was announced on 06/01/17.